{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T05:23:20Z","timestamp":1733808200423,"version":"3.30.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,9]]},"DOI":"10.7759\/cureus.75395","type":"journal-article","created":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T20:51:59Z","timestamp":1733777519000},"source":"Crossref","is-referenced-by-count":0,"title":["A Narrative Review of Old and Emerging Treatment Modalities for Substance Use Disorders"],"prefix":"10.7759","author":[{"given":"Tamanna","family":"Ahluwalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ishan","family":"Gujral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Okafor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R","family":"Hubbard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"DSM-5 Criteria for Addiction Simplified. (2020). Accessed. August 30, 2024: https:\/\/www.addictionpolicy.org\/post\/dsm-5-facts-and-figures."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2022.871459","article-title":"Does childhood adversity lead to drug addiction in adulthood? A study of serial mediators based on resilience and depression","volume":"13","author":"He J","year":"2022","unstructured":"He J, Yan X, Wang R, Zhao J, Liu J, Zhou C, Zeng Y. Does childhood adversity lead to drug addiction in adulthood? A study of serial mediators based on resilience and depression. Front Psychiatry. 2022, 13:871459. 10.3389\/fpsyt.2022.871459","journal-title":"Front Psychiatry"},{"key":"ref3","unstructured":"HHS, SAMHSA Release 2022 National Survey on Drug Use and Health Data. (2023). Accessed. August 30, 2024: https:\/\/www.samhsa.gov\/newsroom\/press-announcements\/20231113\/hhs-samhsa-release-2022-nsduh-data."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.admecli.2014.02.002","article-title":"Screening and brief intervention for alcohol and other abuse","volume":"25","author":"Harris SK","year":"2014","unstructured":"Harris SK, Louis-Jacques J, Knight JR. Screening and brief intervention for alcohol and other abuse. Adolesc Med State Art Rev. 2014, 25:126-56. 10.1016\/j.admecli.2014.02.002","journal-title":"Adolesc Med State Art Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/01612840.2011.654046","article-title":"Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research","volume":"33","author":"Worley J","year":"2012","unstructured":"Worley J. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research. Issues Ment Health Nurs. 2012, 33:319-28. 10.3109\/01612840.2011.654046","journal-title":"Issues Ment Health Nurs"},{"key":"ref6","article-title":"Facing Addiction in America: The Surgeon General's Report on Alcohol, Drugs, and Health","year":"2016","unstructured":"Facing Addiction in America. The Surgeon General's Report on Alcohol, Drugs, and Health. US Department of Health and Human Services, Washington (DC); 2016."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--tackling the opioid-overdose epidemic","volume":"370","author":"Volkow ND","year":"2014","unstructured":"Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies--tackling the opioid-overdose epidemic. N Engl J Med. 2014, 370:2063-6. 10.1056\/NEJMp1402780","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study","volume":"169","author":"Larochelle MR","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, et al.. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018, 169:137-45. 10.7326\/M17-3107","journal-title":"Ann Intern Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2023.01.037","article-title":"Buprenorphine after nonfatal opioid overdose: reduced mortality risk in Medicare disability beneficiaries","volume":"65","author":"Samples H","year":"2023","unstructured":"Samples H, Nowels MA, Williams AR, Olfson M, Crystal S. Buprenorphine after nonfatal opioid overdose: reduced mortality risk in Medicare disability beneficiaries. Am J Prev Med. 2023, 65:19-29. 10.1016\/j.amepre.2023.01.037","journal-title":"Am J Prev Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201500228","article-title":"Medicaid coverage for methadone maintenance and use of opioid agonist therapy in specialty addiction treatment","volume":"67","author":"Saloner B","year":"2016","unstructured":"Saloner B, Stoller KB, Barry CL. Medicaid coverage for methadone maintenance and use of opioid agonist therapy in specialty addiction treatment. Psychiatr Serv. 2016, 67:676-9. 10.1176\/appi.ps.201500228","journal-title":"Psychiatr Serv"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2005.08.002","article-title":"Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study","volume":"81","author":"Carroll KM","year":"2006","unstructured":"Carroll KM, Ball SA, Nich C, et al.. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: a multisite effectiveness study. Drug Alcohol Depend. 2006, 81:301-12. 10.1016\/j.drugalcdep.2005.08.002","journal-title":"Drug Alcohol Depend"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.04.018","article-title":"A \"community-friendly\" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial","volume":"104","author":"Weiss RD","year":"2009","unstructured":"Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GM. A \"community-friendly\" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend. 2009, 104:212-9. 10.1016\/j.drugalcdep.2009.04.018","journal-title":"Drug Alcohol Depend"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman SE","year":"2020","unstructured":"Wakeman SE, Larochelle MR, Ameli O, et al.. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020, 3:e1920622. 10.1001\/jamanetworkopen.2019.20622","journal-title":"JAMA Netw Open"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076336","article-title":"Effect of risk mitigation guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study","volume":"384","author":"Slaunwhite A","year":"2024","unstructured":"Slaunwhite A, Min JE, Palis H, et al.. Effect of risk mitigation guidance for opioid and stimulant dispensations on mortality and acute care visits during dual public health emergencies: retrospective cohort study. BMJ. 2024, 384:e076336. 10.1136\/bmj-2023-076336","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo L","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, et al.. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017, 357:j1550. 10.1136\/bmj.j1550","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.evalprogplan.2011.02.004","article-title":"Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure","volume":"34","author":"Knudsen HK","year":"2011","unstructured":"Knudsen HK, Abraham AJ, Oser CB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval Program Plann. 2011, 34:375-81. 10.1016\/j.evalprogplan.2011.02.004","journal-title":"Eval Program Plann"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2018.02.006","article-title":"Prescribing practices of rural physicians waivered to prescribe buprenorphine","volume":"54","author":"Andrilla CH","year":"2018","unstructured":"Andrilla CH, Coulthard C, Patterson DG. Prescribing practices of rural physicians waivered to prescribe buprenorphine. Am J Prev Med. 2018, 54:S208-14. 10.1016\/j.amepre.2018.02.006","journal-title":"Am J Prev Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-06257-4","article-title":"Barriers and facilitators to the use of medications for opioid use disorder: a rapid review","volume":"35","author":"Mackey K","year":"2020","unstructured":"Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Barriers and facilitators to the use of medications for opioid use disorder: a rapid review. J Gen Intern Med. 2020, 35:954-63. 10.1007\/s11606-020-06257-4","journal-title":"J Gen Intern Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/M20-1210","article-title":"When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis","volume":"173","author":"Becker WC","year":"2020","unstructured":"Becker WC, Fiellin DA. When epidemics collide: coronavirus disease 2019 (COVID-19) and the opioid crisis. Ann Intern Med. 2020, 173:59-60. 10.7326\/M20-1210","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0898-0","article-title":"An overdose surge will compound the COVID-19 pandemic if urgent action is not taken","volume":"26","author":"Wakeman SE","year":"2020","unstructured":"Wakeman SE, Green TC, Rich J. An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nat Med. 2020, 26:819-20. 10.1038\/s41591-020-0898-0","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpr.2021.102110","article-title":"Expanding the continuum of substance use disorder treatment: Nonabstinence approaches","volume":"91","author":"Paquette CE","year":"2022","unstructured":"Paquette CE, Daughters SB, Witkiewitz K. Expanding the continuum of substance use disorder treatment: Nonabstinence approaches. Clin Psychol Rev. 2022, 91:102110. 10.1016\/j.cpr.2021.102110","journal-title":"Clin Psychol Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/16066350500489261","article-title":"Working with controlled use as a goal in regular substance use outpatient treatment in Amsterdam","volume":"14","author":"Schippers GM","year":"2006","unstructured":"Schippers GM, Nelissen H. Working with controlled use as a goal in regular substance use outpatient treatment in Amsterdam. Addict Res Theory. 2006, 14:51-8. 10.1080\/16066350500489261","journal-title":"Addict Res Theory"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s11414-019-09657-5","article-title":"Evaluation of an integrated intensive cognitive behavioral therapy treatment within addiction care","volume":"47","author":"Bador K","year":"2020","unstructured":"Bador K, Kerekes N. Evaluation of an integrated intensive cognitive behavioral therapy treatment within addiction care. J Behav Health Serv Res. 2020, 47:102-12. 10.1007\/s11414-019-09657-5","journal-title":"J Behav Health Serv Res"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.copsyc.2019.04.001","article-title":"Exercise in the context of substance use treatment: key issues and future directions","volume":"30","author":"Abrantes AM","year":"2019","unstructured":"Abrantes AM, Blevins CE. Exercise in the context of substance use treatment: key issues and future directions. Curr Opin Psychol. 2019, 30:103-8. 10.1016\/j.copsyc.2019.04.001","journal-title":"Curr Opin Psychol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110728","article-title":"Impact of physical exercise on substance use disorders: a meta-analysis","volume":"9","author":"Wang D","year":"2014","unstructured":"Wang D, Wang Y, Wang Y, Li R, Zhou C. Impact of physical exercise on substance use disorders: a meta-analysis. PLoS One. 2014, 9:e110728. 10.1371\/journal.pone.0110728","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mhpa.2010.03.001","article-title":"A pilot study of aerobic exercise as an adjunctive treatment for drug dependence","volume":"3","author":"Brown RA","year":"2010","unstructured":"Brown RA, Abrantes AM, Read JP, et al.. A pilot study of aerobic exercise as an adjunctive treatment for drug dependence. Ment Health Phys Act. 2010, 3:27-34. 10.1016\/j.mhpa.2010.03.001","journal-title":"Ment Health Phys Act"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.09.002","article-title":"Exercise as an adjunctive treatment for substance use disorders: rationale and intervention description","volume":"72","author":"Weinstock J","year":"2017","unstructured":"Weinstock J, Farney MR, Elrod NM, Henderson CE, Weiss EP. Exercise as an adjunctive treatment for substance use disorders: rationale and intervention description. J Subst Abuse Treat. 2017, 72:40-7. 10.1016\/j.jsat.2016.09.002","journal-title":"J Subst Abuse Treat"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1037\/adb0000517","article-title":"Reinforcing exercise to improve drug abuse treatment outcomes: A randomized controlled study in a substance use disorder outpatient treatment setting","volume":"34","author":"Alessi SM","year":"2020","unstructured":"Alessi SM, Rash CJ, Pescatello LS. Reinforcing exercise to improve drug abuse treatment outcomes: A randomized controlled study in a substance use disorder outpatient treatment setting. Psychol Addict Behav. 2020, 34:52-64. 10.1037\/adb0000517","journal-title":"Psychol Addict Behav"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.11.019","article-title":"Exercise training - a beneficial intervention in the treatment of alcohol use disorders?","volume":"160","author":"Stoutenberg M","year":"2016","unstructured":"Stoutenberg M, Rethorst CD, Lawson O, Read JP. Exercise training - a beneficial intervention in the treatment of alcohol use disorders?. Drug Alcohol Depend. 2016, 160:2-11. 10.1016\/j.drugalcdep.2015.11.019","journal-title":"Drug Alcohol Depend"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2020.106667","article-title":"Physical activity: a promising adjunctive treatment for severe alcohol use disorder","volume":"113","author":"Cab\u00e9 N","year":"2021","unstructured":"Cab\u00e9 N, Lani\u00e8pce A, Pitel AL. Physical activity: a promising adjunctive treatment for severe alcohol use disorder. Addict Behav. 2021, 113:106667. 10.1016\/j.addbeh.2020.106667","journal-title":"Addict Behav"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1159\/000525268","article-title":"The treatment of substance use disorders: recent developments and new perspectives","volume":"81","author":"Rosenthal A","year":"2022","unstructured":"Rosenthal A, Ebrahimi C, Wedemeyer F, Romanczuk-Seiferth N, Beck A. The treatment of substance use disorders: recent developments and new perspectives. Neuropsychobiology. 2022, 81:451-72. 10.1159\/000525268","journal-title":"Neuropsychobiology"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.05.031","article-title":"Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a systematic review and meta-analysis","volume":"154","author":"Lai HM","year":"2015","unstructured":"Lai HM, Cleary M, Sitharthan T, Hunt GE. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: a systematic review and meta-analysis. Drug Alcohol Depend. 2015, 154:1-13. 10.1016\/j.drugalcdep.2015.05.031","journal-title":"Drug Alcohol Depend"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2019-0725","article-title":"The contribution of mindfulness to outpatient substance use disorder treatment in Brazil: a preliminary study","volume":"42","author":"Machado MP","year":"2020","unstructured":"Machado MP, Fidalgo TM, Brasiliano S, Hochgraf PB, Noto AR. The contribution of mindfulness to outpatient substance use disorder treatment in Brazil: a preliminary study. Braz J Psychiatry. 2020, 42:527-31. 10.1590\/1516-4446-2019-0725","journal-title":"Braz J Psychiatry"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S132255","article-title":"Acceptance and commitment therapy for clients institutionalized for severe substance-use disorder: a pilot study","volume":"8","author":"Svanberg G","year":"2017","unstructured":"Svanberg G, Munck I, Levander M. Acceptance and commitment therapy for clients institutionalized for severe substance-use disorder: a pilot study. Subst Abuse Rehabil. 2017, 8:45-51. 10.2147\/SAR.S132255","journal-title":"Subst Abuse Rehabil"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2018.17090978","article-title":"Randomized clinical trial of computerized and clinician-delivered CBT in comparison with standard outpatient treatment for substance use disorders: Primary within-treatment and follow-up outcomes","volume":"175","author":"Kiluk BD","year":"2018","unstructured":"Kiluk BD, Nich C, Buck MB, et al.. Randomized clinical trial of computerized and clinician-delivered CBT in comparison with standard outpatient treatment for substance use disorders: Primary within-treatment and follow-up outcomes. Am J Psychiatry. 2018, 175:853-63. 10.1176\/appi.ajp.2018.17090978","journal-title":"Am J Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s40617-022-00730-8","article-title":"Feasibility, acceptability, and preliminary efficacy of a smartphone-based contingency management intervention for buprenorphine adherence","volume":"16","author":"DeFulio A","year":"2023","unstructured":"DeFulio A, Brown HD, Davidson RM, Regnier SD, Kang N, Ehart M. Feasibility, acceptability, and preliminary efficacy of a smartphone-based contingency management intervention for buprenorphine adherence. Behav Anal Pract. 2023, 16:450-8. 10.1007\/s40617-022-00730-8","journal-title":"Behav Anal Pract"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1192\/pb.bp.110.031831","article-title":"Contingency management: what it is and why psychiatrists should want to use it","volume":"35","author":"Petry NM","year":"2011","unstructured":"Petry NM. Contingency management: what it is and why psychiatrists should want to use it. Psychiatrist. 2011, 35:161-3. 10.1192\/pb.bp.110.031831","journal-title":"Psychiatrist"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2018.12.975","article-title":"Effects of single-session versus multi-session non-invasive brain stimulation on craving and consumption in individuals with drug addiction, eating disorders or obesity: a meta-analysis","volume":"12","author":"Song S","year":"2019","unstructured":"Song S, Zilverstand A, Gui W, Li HJ, Zhou X. Effects of single-session versus multi-session non-invasive brain stimulation on craving and consumption in individuals with drug addiction, eating disorders or obesity: a meta-analysis. Brain Stimul. 2019, 12:606-18. 10.1016\/j.brs.2018.12.975","journal-title":"Brain Stimul"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2023.2247071","article-title":"Re-purposing FDA-approved drugs for opioid use disorder","volume":"58","author":"Patel K","year":"2023","unstructured":"Patel K, Waldron D, Graziane N. Re-purposing FDA-approved drugs for opioid use disorder. Subst Use Misuse. 2023, 58:1751-60. 10.1080\/10826084.2023.2247071","journal-title":"Subst Use Misuse"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2019.1607956","article-title":"Short-term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine","volume":"51","author":"Berlowitz I","year":"2019","unstructured":"Berlowitz I, Walt H, Ghasarian C, Mendive F, Martin-Soelch C. Short-term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine. J Psychoactive Drugs. 2019, 51:323-34. 10.1080\/02791072.2019.1607956","journal-title":"J Psychoactive Drugs"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.626010","article-title":"Role of cannabidiol in the therapeutic intervention for substance use disorders","volume":"12","author":"Navarrete F","year":"2021","unstructured":"Navarrete F, Garc\u00eda-Guti\u00e9rrez MS, Gasparyan A, Austrich-Olivares A, Manzanares J. Role of cannabidiol in the therapeutic intervention for substance use disorders. Front Pharmacol. 2021, 12:626010. 10.3389\/fphar.2021.626010","journal-title":"Front Pharmacol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2023.2190319","article-title":"Psychedelic treatments for substance use disorder and substance misuse: a mixed methods systematic review","volume":"55","author":"Sharma R","year":"2023","unstructured":"Sharma R, Batchelor R, Sin J. Psychedelic treatments for substance use disorder and substance misuse: a mixed methods systematic review. J Psychoactive Drugs. 2023, 55:612-30. 10.1080\/02791072.2023.2190319","journal-title":"J Psychoactive Drugs"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/296192-a-narrative-review-of-old-and-emerging-treatment-modalities-for-substance-use-disorders","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T20:52:02Z","timestamp":1733777522000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/296192-a-narrative-review-of-old-and-emerging-treatment-modalities-for-substance-use-disorders"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":42,"URL":"https:\/\/doi.org\/10.7759\/cureus.75395","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,9]]}}}